68.41 USD
-0.23
0.34%
At close Apr 24, 4:00 PM EDT
After hours
68.41
+0.00
0.00%
1 day
-0.34%
5 days
0.71%
1 month
0.29%
3 months
12.48%
6 months
3.71%
Year to date
18.03%
1 year
56.87%
5 years
146.88%
10 years
-6.06%
 

About: Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.

Employees: 498

0
Funds holding %
of 7,419 funds
0
Analysts bullish %
of 7 analysts

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

60% more first-time investments, than exits

New positions opened: 112 | Existing positions closed: 70

30% more repeat investments, than reductions

Existing positions increased: 296 | Existing positions reduced: 227

5% more funds holding

Funds holding: 710 [Q3] → 742 (+32) [Q4]

2.72% more ownership

Funds ownership: 94.87% [Q3] → 97.59% (+2.72%) [Q4]

4% more call options, than puts

Call options by funds: $47.7M | Put options by funds: $45.6M

0% less capital invested

Capital invested by funds: $25.2B [Q3] → $25.2B (-$24.8M) [Q4]

27% less funds holding in top 10

Funds holding in top 10: 15 [Q3] → 11 (-4) [Q4]

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$70
2%
upside
Avg. target
$74
8%
upside
High target
$78
14%
upside

7 analyst ratings

positive
57%
neutral
43%
negative
0%
Mizuho
Vikram Malhorta
54% 1-year accuracy
7 / 13 met price target
10%upside
$75
Outperform
Maintained
18 Mar 2025
Morgan Stanley
Richard Hill
0% 1-year accuracy
0 / 1 met price target
2%upside
$70
Equal-Weight
Maintained
11 Mar 2025
Wells Fargo
John Kilichowski
72% 1-year accuracy
13 / 18 met price target
13%upside
$77
Overweight
Maintained
10 Mar 2025
JP Morgan
Michael Mueller
53% 1-year accuracy
8 / 15 met price target
7%upside
$73
Neutral
Maintained
7 Mar 2025
Scotiabank
Nicholas Yulico
37% 1-year accuracy
16 / 43 met price target
5%upside
$72
Sector Perform
Maintained
28 Feb 2025

Financial journalist opinion

Based on 10 articles about VTR published over the past 30 days

Positive
Zacks Investment Research
5 hours ago
Ventas (VTR) is a Top Dividend Stock Right Now: Should You Buy?
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Ventas (VTR) have what it takes?
Ventas (VTR) is a Top Dividend Stock Right Now: Should You Buy?
Negative
Seeking Alpha
3 days ago
The State Of REITs: April 2025 Edition
REITs finished the first quarter of 2025 in the red (-3.36%) with a brutal -4.92% average total return in March. Large cap (-2.04%) and mid cap REITs (-2.63%) saw modest losses, but small caps (-4.16%) and micro caps (-16.19%) had a particularly bad month. Only 29.49% of REIT securities had a positive total return in March.
The State Of REITs: April 2025 Edition
Positive
Investors Business Daily
3 days ago
Analysts Say 12 Stocks Will Profit Most From Trump's Reign
First-quarter earnings season is in full swing. But investors playing the long game want to know which S&P 500 companies will profit most.
Analysts Say 12 Stocks Will Profit Most From Trump's Reign
Positive
Zacks Investment Research
1 week ago
Ventas Stock Surges 13.9% in Three Months: Will the Trend Last?
Aging population, rising healthcare expenses, favorable outpatient visit trends and accretive investments in its research portfolio are likely to support VTR.
Ventas Stock Surges 13.9% in Three Months: Will the Trend Last?
Positive
Schwab Network
2 weeks ago
The Big 3: TJX, VTR, ORCL
Jessica Inskip turns to three companies she believes can rally as winners in a tariff-induced market. She points to TJX Companies' (TJX) ability to adjust its supply chain, Ventas' (VTR) margin strength due to its aging population, and Oracle's (ORCL) potential TikTok tailwind.
The Big 3: TJX, VTR, ORCL
Positive
Zacks Investment Research
2 weeks ago
This is Why Ventas (VTR) is a Great Dividend Stock
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Ventas (VTR) have what it takes?
This is Why Ventas (VTR) is a Great Dividend Stock
Positive
Seeking Alpha
2 weeks ago
Why Ventas Is Poised For Strong Long-Term Returns
Ventas is a well-run REIT that's experiencing high growth, particularly in its SHOP portfolio. It carries a strong balance sheet and management has resumed meaningful dividend growth. The recent dip in price has brought the yield to 3%. Combined with high single digit FFO/share growth, VTR could deliver potential market-beating total returns.
Why Ventas Is Poised For Strong Long-Term Returns
Neutral
Business Wire
2 weeks ago
Ventas Announces First Quarter 2025 Earnings Release Date and Conference Call
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) will issue its first quarter 2025 earnings release after the close of trading on the New York Stock Exchange on Wednesday, April 30, 2025. A conference call to discuss those earnings will be held on Thursday, May 1, 2025 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The dial-in number for the conference call is (888) 330-3576 (or +1 (646) 960-0672 for international callers), and the participant passcode is 7655497. A live webcast can be.
Ventas Announces First Quarter 2025 Earnings Release Date and Conference Call
Neutral
Zacks Investment Research
3 weeks ago
Here's Why You Should Retain Ventas Stock in Your Portfolio Now
Rising healthcare expenditures and an aging population support VTR's senior housing operating portfolio despite competition and tenant concentration risks.
Here's Why You Should Retain Ventas Stock in Your Portfolio Now
Neutral
CNBC Television
3 weeks ago
Cramer's Stop Trading: Ventas
Jim Cramer breaks down why he's keeping an eye on shares of Ventas.
Cramer's Stop Trading: Ventas
Charts implemented using Lightweight Charts™